Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. [electronic resource]
Producer: 20071220Description: 1071-1078 p. digitalISSN:- 1474-5488
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Docetaxel
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Neoplastic
- Genetic Testing -- methods
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Oligonucleotide Array Sequence Analysis
- Patient Selection
- Predictive Value of Tests
- ROC Curve
- Receptors, Estrogen -- analysis
- Reproducibility of Results
- Sensitivity and Specificity
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.